Anti-HIV drugs.

As of now, there are 22 formulations that have been officially endorsed (by the Food and Drug Administration of India) for the treatment of HIV diseases (AIDS). As indicated by the location of their mediation with the HIV replication cycle, these mixtures can be organized into 4 classifications:


HIV disease (AIDS) treatment


(1)  NRTIs (nucleoside switch transcriptase inhibitors): azidothymidine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine 


 (2)  NTRTI (nucleotide turn around transcriptase inhibitor): tenofovir, directed as its oral prodrug structure TDF (tenofovir disoproxil fumarate


(3)  NNRTIs (non-nucleoside invert transcriptase inhibitors): nevirapine, delavirdine and efavirenz


 (4)  PI (HIV protease inhibitors): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir, atazanavir, fosamprenavir, tipranavir, and darunavir


 AIDS Treatment and Medicines


 Various combinations of drugs are currently available for the treatment of AIDS. Drug mixtures, at the fundamental level, tend to achieve synergy between mixtures (understandably they act by different devices), while the potential for drug barrier improvement is reduced. One such enemy of the anti-HIV drugs mix system was introduced about 10 years ago and is known as HAART (for Extraordinary Dynamic Antiretroviral Treatment). While HAART initially included a pill weight of pills each day (at least twenty), this has steadily decreased in recent years, and since July 2008, and over the board pill (Atripla) has been introduced, Contains three anti-HIV Cure medicines (tenofovir disoproxil fumarate, emtricitabine, and efavirenz) to be taken as a single tablet only once a day. Given the data obtained in recent years on the therapeutic use (adequacy, safety) of tenofovir disoproxil fumarate, it would now seem imperative to consider additionally the prophylactic use of TDF [and its combination with emtricitabine (Truvada)]. ) as well as Atripla], as one tablet daily to prevent HIV disease.

Contact information 

address:

S-14, Ist Floor, Uphaar Cinema Complex Market,Green Park Extn., New Delhi-110016

Email ID: sales@aarkpharma.com

Tel: +91-9953466646

Website - https://www.aarkpharma.com/

Comments

Popular posts from this blog

Volantis-Everolimus: A Promising Breakthrough in Medical Treatment

Hematology Medicines- Access To Human Wellbeing

The Alzumab-L Itolizumab Injection | 100Mg uses, side effects, price, and substitutes